Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.

Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M, Ballerini P, Cazzaniga G, Moreno T, Revilla C, Gut M, Valsecchi MG, Roberts I, Pieters R, De Lorenzo P, Varela I, Menendez P, Stam RW.

Haematologica. 2019 Jun;104(6):1176-1188. doi: 10.3324/haematol.2018.206375. Epub 2019 Jan 24.

2.

Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.

Prieto C, López-Millán B, Roca-Ho H, Stam RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V, Ramírez M, Bardini M, De Lorenzo P, Valsecchi MG, Stanulla M, Iglesias M, Ballerini P, Carcaboso ÁM, Mora J, Locatelli F, Bertaina A, Padilla L, Rodríguez-Manzaneque JC, Bueno C, Menéndez P.

Leukemia. 2018 Oct;32(10):2306. doi: 10.1038/s41375-018-0236-4.

PMID:
30218009
3.

Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL.

Bardini M, Trentin L, Rizzo F, Vieri M, Savino AM, Garrido Castro P, Fazio G, Van Roon EHJ, Kerstjens M, Smithers N, Prinjha RK, Te Kronnie G, Basso G, Stam RW, Pieters R, Biondi A, Cazzaniga G.

Mol Cancer Ther. 2018 Aug;17(8):1705-1716. doi: 10.1158/1535-7163.MCT-17-1123. Epub 2018 May 10.

PMID:
29748211
4.

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.

Magnani CF, Mezzanotte C, Cappuzzello C, Bardini M, Tettamanti S, Fazio G, Cooper LJN, Dastoli G, Cazzaniga G, Biondi A, Biagi E.

Hum Gene Ther. 2018 May;29(5):602-613. doi: 10.1089/hum.2017.207. Epub 2018 Apr 16.

PMID:
29641322
5.

Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.

Cipriano A, Pecori A, Bionda AE, Bardini M, Frassi F, Leoli F, Lami V, Ghiadoni L, Santini M.

Intern Emerg Med. 2018 Oct;13(7):1077-1087. doi: 10.1007/s11739-018-1806-1. Epub 2018 Mar 8.

PMID:
29520701
6.

NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.

Prieto C, López-Millán B, Roca-Ho H, Stam RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V, Ramírez M, Bardini M, De Lorenzo P, Valsecchi MG, Stanulla M, Iglesias M, Ballerini P, Carcaboso ÁM, Mora J, Locatelli F, Bertaina A, Padilla L, Rodríguez-Manzaneque JC, Bueno C, Menéndez P.

Leukemia. 2018 Mar;32(3):633-644. doi: 10.1038/leu.2017.294. Epub 2017 Sep 25. Erratum in: Leukemia. 2018 Oct;32(10):2306.

7.

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Savino AM, Sarno J, Trentin L, Vieri M, Fazio G, Bardini M, Bugarin C, Fossati G, Davis KL, Gaipa G, Izraeli S, Meyer LH, Nolan GP, Biondi A, Te Kronnie G, Palmi C, Cazzaniga G.

Leukemia. 2017 Nov;31(11):2365-2375. doi: 10.1038/leu.2017.93. Epub 2017 Mar 23.

PMID:
28331226
8.

Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis.

Trentin L, Bresolin S, Giarin E, Bardini M, Serafin V, Accordi B, Fais F, Tenca C, De Lorenzo P, Valsecchi MG, Cazzaniga G, Kronnie GT, Basso G.

Sci Rep. 2016 Oct 4;6:34449. doi: 10.1038/srep34449.

9.

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.

Muñoz-López A, Romero-Moya D, Prieto C, Ramos-Mejía V, Agraz-Doblas A, Varela I, Buschbeck M, Palau A, Carvajal-Vergara X, Giorgetti A, Ford A, Lako M, Granada I, Ruiz-Xivillé N, Rodríguez-Perales S, Torres-Ruíz R, Stam RW, Fuster JL, Fraga MF, Nakanishi M, Cazzaniga G, Bardini M, Cobo I, Bayon GF, Fernandez AF, Bueno C, Menendez P.

Stem Cell Reports. 2016 Oct 11;7(4):602-618. doi: 10.1016/j.stemcr.2016.08.013. Epub 2016 Sep 22.

10.

LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.

Cazzaniga V, Bugarin C, Bardini M, Giordan M, te Kronnie G, Basso G, Biondi A, Fazio G, Cazzaniga G.

Oncotarget. 2015 Jan 30;6(3):1569-81.

11.

Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.

Frau F, Zaninello R, Salvi E, Ortu MF, Braga D, Velayutham D, Argiolas G, Fresu G, Troffa C, Bulla E, Bulla P, Pitzoi S, Piras DA, Glorioso V, Chittani M, Bernini G, Bardini M, Fallo F, Malatino L, Stancanelli B, Regolisti G, Ferri C, Desideri G, Scioli GA, Galletti F, Sciacqua A, Perticone F, Degli Esposti E, Sturani A, Semplicini A, Veglio F, Mulatero P, Williams TA, Lanzani C, Hiltunen TP, Kontula K, Boerwinkle E, Turner ST, Manunta P, Barlassina C, Cusi D, Glorioso N.

Pharmacogenomics. 2014 Sep;15(13):1643-52. doi: 10.2217/pgs.14.119.

PMID:
25410890
12.

Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.

Bardini M, Woll PS, Corral L, Luc S, Wittmann L, Ma Z, Lo Nigro L, Basso G, Biondi A, Cazzaniga G, Jacobsen SE.

Leukemia. 2015 Jan;29(1):38-50. doi: 10.1038/leu.2014.154. Epub 2014 May 6.

PMID:
24798483
13.

Interval type-2 fuzzy neural network controller for a multivariable anesthesia system based on a hardware-in-the-loop simulation.

El-Nagar AM, El-Bardini M.

Artif Intell Med. 2014 May;61(1):1-10. doi: 10.1016/j.artmed.2014.03.002. Epub 2014 Mar 19.

PMID:
24703775
14.

Interval type-2 fuzzy PID controller for uncertain nonlinear inverted pendulum system.

El-Bardini M, El-Nagar AM.

ISA Trans. 2014 May;53(3):732-43. doi: 10.1016/j.isatra.2014.02.007. Epub 2014 Mar 21.

PMID:
24661774
15.

Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.

Carozzi VA, Renn CL, Bardini M, Fazio G, Chiorazzi A, Meregalli C, Oggioni N, Shanks K, Quartu M, Serra MP, Sala B, Cavaletti G, Dorsey SG.

PLoS One. 2013 Sep 12;8(9):e72995. doi: 10.1371/journal.pone.0072995. eCollection 2013.

16.

The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia.

Dobbins SE, Sherborne AL, Ma YP, Bardini M, Biondi A, Cazzaniga G, Lloyd A, Chubb D, Greaves MF, Houlston RS.

Genes Chromosomes Cancer. 2013 Oct;52(10):954-60. doi: 10.1002/gcc.22090. Epub 2013 Jul 26.

PMID:
23893660
17.

Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.

Bardini M, Galbiati M, Lettieri A, Bungaro S, Gorletta TA, Biondi A, Cazzaniga G.

Leukemia. 2011 Jan;25(1):175-8. doi: 10.1038/leu.2010.232. Epub 2010 Oct 14. No abstract available.

PMID:
20944671
18.

Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.

O'Connor KC, Lopez-Amaya C, Gagne D, Lovato L, Moore-Odom NH, Kennedy J, Krupp L, Tenembaum S, Ness J, Belman A, Boyko A, Bykova O, Mah JK, Stoian CA, Waubant E, Kremenchutzky M, Ruggieri M, Bardini MR, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman MS, Iivanainen M, Bhan V, Dilenge M, Hancock MA, Gano D, Fattahie R, Kopel L, Fournier AE, Moscarello M, Banwell B, Bar-Or A.

J Neuroimmunol. 2010 Jun;223(1-2):92-9. doi: 10.1016/j.jneuroim.2010.02.019. Epub 2010 Apr 8.

PMID:
20381173
19.

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4.

Bardini M, Spinelli R, Bungaro S, Mangano E, Corral L, Cifola I, Fazio G, Giordan M, Basso G, De Rossi G, Biondi A, Battaglia C, Cazzaniga G.

Leukemia. 2010 Jan;24(1):169-76. doi: 10.1038/leu.2009.203. Epub 2009 Nov 12.

PMID:
19907438
20.

Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism.

Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, Ghiadoni L, Bernini M, Santoro G, Salvetti A.

J Hypertens. 2008 Dec;26(12):2399-405. doi: 10.1097/HJH.0b013e32831286fd.

PMID:
19008719
21.

Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodelling.

Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Moretti A, Bernini M, Berti P, Miccoli P, Salvetti A.

Eur J Endocrinol. 2008 Aug;159(2):137-43. doi: 10.1530/EJE-08-0126. Epub 2008 May 21.

PMID:
18495696
22.

Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.

Bernini G, Moretti A, Orlandini C, Berti P, Miccoli P, Bardini M, Taurino C, Bernini M, Salvetti A.

J Hypertens. 2008 May;26(5):981-8. doi: 10.1097/HJH.0b013e3282f61f8c.

PMID:
18398341
23.

Conceptual basis and methodology of the SOPHIA study.

Glorioso N, Argiolas G, Filigheddu F, Troffa C, Cocco F, Bulla E, Bulla P, Zaninello R, Degortes S, Pitzoi S, Frau F, Fadda S, Pinna Parpaglia P, Bernini G, Bardini M, Fallo F, Malatino L, Regolisti G, Ferri C, Cusi D, Sciacqua A, Perticone F, Degli Esposti E, Baraccani C, Parati G, Veglio F, Mulatero P, Williams TA, Macciardi F, Stancanelli B; Study Group on Cardiovascular Pharmacogenomics of Italian Society of Hypertension.

Pharmacogenomics. 2007 Nov;8(11):1497-509.

PMID:
18034615
24.

Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter.

Galetta F, Bernini G, Franzoni F, Tocchini L, Taurino C, Bardini M, Rossi M, Salvetti A, Santoro G.

Clin Endocrinol (Oxf). 2008 May;68(5):756-61. Epub 2007 Nov 19.

PMID:
18031325
25.

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.

Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A.

Lancet Neurol. 2007 Sep;6(9):773-81.

PMID:
17689148
26.

Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.

Iotti G, Ferrari-Amorotti G, Rosafio C, Corradini F, Lidonnici MR, Ronchetti M, Bardini M, Zhang Y, Martinez R, Blasi F, Calabretta B.

Oncogene. 2007 May 24;26(24):3482-91. Epub 2006 Dec 11.

PMID:
17160016
27.

Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities.

Guerzoni C, Ferrari-Amorotti G, Bardini M, Mariani SA, Calabretta B.

Cell Cycle. 2006 Jun;5(12):1254-7. Epub 2006 Jun 15.

PMID:
16760662
28.

Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy.

Bernini G, Versari D, Moretti A, Virdis A, Ghiadoni L, Bardini M, Taurino C, Canale D, Taddei S, Salvetti A.

J Clin Endocrinol Metab. 2006 May;91(5):1691-7. Epub 2006 Feb 21.

PMID:
16492703
29.

Carotid vascular remodeling in patients with pheochromocytoma.

Bernini G, Franzoni F, Galetta F, Moretti A, Taurino C, Bardini M, Santoro G, Ghiadoni L, Bernini M, Salvetti A.

J Clin Endocrinol Metab. 2006 May;91(5):1754-60. Epub 2006 Feb 21.

PMID:
16492700
30.

Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene.

Bernini GP, Moretti A, Mannelli M, Ercolino T, Bardini M, Caramella D, Taurino C, Salvetti A.

J Endocrinol Invest. 2005 Dec;28(11):1032-7.

PMID:
16483185
31.

Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Guerzoni C, Bardini M, Mariani SA, Ferrari-Amorotti G, Neviani P, Panno ML, Zhang Y, Martinez R, Perrotti D, Calabretta B.

Blood. 2006 May 15;107(10):4080-9. Epub 2006 Jan 17.

32.

Functional analysis of DNA sequences controlling the expression of the rice OsCDPK2 gene.

Morello L, Bardini M, Cricrì M, Sala F, Breviario D.

Planta. 2006 Feb;223(3):479-91. Epub 2005 Oct 1.

PMID:
16200411
33.

Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas.

Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C, Salvetti A.

Br J Cancer. 2005 Mar 28;92(6):1104-9.

34.

P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium.

Jiang L, Bardini M, Keogh A, dos Remedios CG, Burnstock G.

Int J Cardiol. 2005 Feb 15;98(2):291-7.

PMID:
15686781
35.

Plasma and tissue chromogranin in patients with adrenocortical adenomas.

Bernini GP, Moretti A, Borgioli M, Bardini M, Miccoli P, Berti P, Basolo F, Faviana P, Birindelli R, Salvetti A.

J Endocrinol Invest. 2004 Oct;27(9):821-5.

PMID:
15648545
36.

Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.

Bernini G, Moretti A, Fontana V, Orlandini C, Miccoli P, Berti P, Basolo F, Faviana P, Bardini M, Salvetti A.

Eur J Endocrinol. 2004 Aug;151(2):215-22.

PMID:
15296477
37.

Tubulin-based polymorphism (TBP): a new tool, based on functionally relevant sequences, to assess genetic diversity in plant species.

Bardini M, Lee D, Donini P, Mariani A, Gianì S, Toschi M, Lowe C, Breviario D.

Genome. 2004 Apr;47(2):281-91.

PMID:
15060580
38.

Tubulin intron sequences: multi-functional tools.

GianI S, Morello L, Bardini M, Breviario D.

Cell Biol Int. 2003;27(3):203-5. No abstract available.

PMID:
12681308
39.

P2 receptors in the murine gastrointestinal tract.

Giaroni C, Knight GE, Ruan HZ, Glass R, Bardini M, Lecchini S, Frigo G, Burnstock G.

Neuropharmacology. 2002 Dec;43(8):1313-23.

PMID:
12527481
41.

Changes in P2X receptor responses of sensory neurons from P2X3-deficient mice.

Zhong Y, Dunn PM, Bardini M, Ford AP, Cockayne DA, Burnstock G.

Eur J Neurosci. 2001 Dec;14(11):1784-92.

PMID:
11860473
42.

Evidence for the involvement of purinergic signalling in the control of respiration.

Thomas T, Ralevic V, Bardini M, Burnstock G, Spyer KM.

Neuroscience. 2001;107(3):481-90.

PMID:
11719002
43.

Expression of nucleotide P2X receptor subtypes during spermatogenesis in the adult rat testis.

Glass R, Bardini M, Robson T, Burnstock G.

Cells Tissues Organs. 2001;169(4):377-87.

PMID:
11490117
44.

P2X3 knock-out mice reveal a major sensory role for urothelially released ATP.

Vlaskovska M, Kasakov L, Rong W, Bodin P, Bardini M, Cockayne DA, Ford AP, Burnstock G.

J Neurosci. 2001 Aug 1;21(15):5670-7.

45.

P2X receptor immunoreactivity in the male genital organs of the rat.

Lee HY, Bardini M, Burnstock G.

Cell Tissue Res. 2000 May;300(2):321-30.

PMID:
10867827
46.

Distribution of P2X receptors in the urinary bladder and the ureter of the rat.

Lee HY, Bardini M, Burnstock G.

J Urol. 2000 Jun;163(6):2002-7.

PMID:
10799247
47.

Distribution of P2X receptor subtypes in the rat female reproductive tract at late pro-oestrus/early oestrus.

Bardini M, Lee HY, Burnstock G.

Cell Tissue Res. 2000 Jan;299(1):105-13.

PMID:
10654074
48.

P2X receptors in the rat duodenal villus.

Gröschel-Stewart U, Bardini M, Robson T, Burnstock G.

Cell Tissue Res. 1999 Jul;297(1):111-7.

PMID:
10398888
49.

Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia.

Gröschel-Stewart U, Bardini M, Robson T, Burnstock G.

Cell Tissue Res. 1999 Jun;296(3):599-605.

PMID:
10370147
50.

P2X purinoceptors in postmortem human cerebral arteries.

Bo X, Karoon P, Nori SL, Bardini M, Burnstock G.

J Cardiovasc Pharmacol. 1998 May;31(5):794-9.

PMID:
9593081

Supplemental Content

Loading ...
Support Center